<div class='question' style='padding-left: 20px;'>
<p>a. 0.3 cm (<em>allow 0.2 to 0.4</em>);<br />b. no difference (because of large error bars);</p>
<div class='question_part_label'>a.</div>
</div>
<div class='question' style='padding-left: 20px;'>
<p>growing spurt not yet started/prepuberty</p>
<div class='question_part_label'>b.</div>
</div>
<div class='question' style='padding-left: 20px;'>
<p>a. causes a reduction in height;<br />b. biggest drop in first year (of treatment);<br />c. levelling off after two years;<br />d. no apparent drop after year two because of overlapping error bars;</p>
<div class='question_part_label'>c.</div>
</div>
<div class='question' style='padding-left: 20px;'>
<p>a. height difference (seen during treatment period) persists into adulthood;<br />b. budesonide group on average about 1.3 cm/13 mm shorter than placebo group / height difference is (likely) unnoticeable/insignificant compared to placebo group;<br />c. benefit from budesonide treatment (probably) outweighs (slight) loss of height;</p>
<div class='question_part_label'>d.</div>
</div>
<div class='question' style='padding-left: 20px;'>
<p>no information on male versus female/diet/ethnic background/health status/medical treatment or history before study/effects on growth at other ages</p>
<div class='question_part_label'>e.</div>
</div>
